Zimbabwe secures HIV/AIDS, Malaria, TB drugs for the whole year

By Gwen Mugauri |  1 year ago | local

 Government says it has adequate drug supplies for the treatment of HIV/AIDS, Malaria and Tuberculosis (TB) to cover the year, a development expected to improve the quality of service delivery towards elimination of these diseases in line with vision 2030 targets.

In an interview with Zimpapers Radio News in Harare yesterday, Health and Child Care deputy director of pharmaceutical services Newman Madzikwa said preparations for the quantification process to ascertain need for 2024 drugs supplies are already underway.

Madzikwa added that a slight shortage of TB drugs experienced by some health facilities towards the end of 2022 has since been rectified.

In 2022, Zimbabwe surpassed the joint United Nations programme on HIV/AIDS (UNAIDS) “95-95-95” global targets of attaining 95 percent in HIV diagnosis, anti-retroviral treatment and viral suppression rates and it also became the first African country to approve a fast-acting injectable pre-exposure prophylaxis aimed at preventing the spread of HIV.